# Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)

> **NCT02838693** · — · UNKNOWN · sponsor: **Medicine** · enrollment: 2300 (estimated)

## Conditions studied

- Pre-diabetes
- Diabetes

## Interventions

- **PROCEDURE:** Not applicable. This is an observational study.

## Key facts

- **NCT ID:** NCT02838693
- **Lead sponsor:** Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 2300 (ESTIMATED)
- **Last updated:** 2016-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838693, "Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02838693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*